An Australian study in JAMA Neurology showed that 50.5% of childhood cancer survivors who underwent neurotoxic chemotherapy had clinical abnormalities in Total Neuropathy Scores. Researchers also found smaller lower limb sural sensory amplitudes, suggesting a reduced number of functioning axons, among those exposed to neurotoxic chemotherapy, compared with controls, while abnormalities were more prevalent among those exposed to cisplatin.
Many childhood cancer survivors develop chemo-induced neuropathy
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.